85 hasil untuk "Javaheri, Ali"
Menampilkan 81–85 · 1,09 detik · RSS
-
Artikel Jurnal Teks lengkap
Effect of Sodium Glucose Cotransporter 2 Inhibitors on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Pragmatic, Multicentre, Open Label, Randomized Controlled Trial
BACKGROUND: Patients hospitalized for Coronavirus disease 2019 (COVID-19) are at risk for multiorgan failure and death. Sodium glucose cotransporter 2 (SGLT2) inhibitors provide cardiovascular and kidney protection in patients with cardiometabolic conditions and may provide organ protection during…
-
Artikel Jurnal Teks lengkap
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial
BACKGROUND: COVID-19 can lead to multiorgan failure. Dapagliflozin, a SGLT2 inhibitor, has significant protective benefits for the heart and kidney. We aimed to see whether this agent might provide organ protection in patients with COVID-19 by affecting processes dysregulated during acute illness…
-
Artikel Jurnal Teks lengkap
Deficiency Of the Deubiquitinase, UCHL1, Attenuates Pulmonary Arterial Hypertension
RATIONALE: While the ubiquitin-proteasome system regulates protein degradation and the development of pulmonary arterial hypertension (PAH), limited is known about the role of deubiquitinating enzymes (DUBs) in this process. Ubiquitin carboxyl-terminal esterase-L1 (UCHL1), a deubiquitinase, has…
-
Artikel Jurnal Teks lengkap
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19
IMPORTANCE: Preclinical models suggest dysregulation of the renin-angiotensin system (RAS) caused by SARS-CoV-2 infection may increase the relative activity of angiotensin II compared with angiotensin (1-7) and may be an important contributor to COVID-19 pathophysiology. OBJECTIVE: To evaluate the…
-
Artikel Jurnal Teks lengkap
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia
IMPORTANCE: Fostamatinib, a spleen tyrosine kinase inhibitor, has been reported to improve outcomes of COVID-19. OBJECTIVE: To evaluate the efficacy and safety of fostamatinib in adults hospitalized with COVID-19 and hypoxemia. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, phase 3…